Search For "hyderabad based bharat biotech"
Central Drugs Standard Control Organisation extends Covaxin shelf life to
Updated : 4 years, 7 months ago IST
New Delhi [India], November 3 (ANI): Hyderabad-based Bharat Biotech's COVID-19 vaccine Covaxin has received an extension of shelf life for up to 12 months from the date of manufacturing on Wednesday by India's pharmaceuticals and medical regulatory body.
Read More
WHO grants approval to Covaxin for emergency use listing
Updated : 4 years, 7 months ago IST
Geneva [Switzerland], November 3 (ANI): The World Health Organisation (WHO), has granted approval for Emergency Use Listing (EUL) for Hyderabad-based Bharat Biotech's COVID-19 vaccine, Covaxin.
Read More
Approval for Covaxin on basis of WHO meeting today: Mansukh Mandaviya
Updated : 4 years, 7 months ago IST
New Delhi [India], October 26 (ANI): Union Health Minister Mansukh Mandaviya on Tuesday said that approval for Hyderabad-based Bharat Biotech's COVID-19 vaccine Covaxin will be given on the basis of the meeting which will be convened by the World Health Organization (WHO) today.
Read More
Administration of ZyCoV-D vaccine requires special training; awaiting NTAG
Updated : 4 years, 7 months ago IST
New Delhi [India], October 21 (ANI): Zydus Cadila's vaccine - ZyCoV-D is the first indigenously manufactured needle-free Covid-19 vaccine which is approved for children aged above 12 for emergency use in the country. Earlier, the Subject Experts Committee (SEC) has also recommended the Hy
Read More
WHO's advisory group to meet on Oct 26 to consider Covaxin's emergency usa
Updated : 4 years, 7 months ago IST
Geneva [Switzerland], October 17 (ANI): Dr Soumya Swaminathan, World Health Organisation (WHO) chief scientist on Sunday informed that WHO's technical advisory group will meet on October 26 to consider emergency use listing (EUL) for Hyderabad-based Bharat Biotech's COVID-19 vaccine Covax
Read More
I'm sure approval of Covaxin from WHO will come at soonest possible, says
Updated : 4 years, 7 months ago IST
Bhubaneswar (Odisha) [India], October 15 (ANI): Foreign Secretary Harsh Vardhan Shringla on Thursday expressed hope that the World Health Organisation (WHO) will soon give approval to Hyderabad-based Bharat Biotech's COVID-19 vaccine Covaxin.
Read More
WHO decision on Covaxin nod extended to next week
Updated : 4 years, 8 months ago IST
Geneva [Switzerland], October 5 (ANI): World Health Organisation (WHO) has extended giving the emergency use authorization for Hyderabad-based Bharat Biotech's COVID-19 vaccine Covaxin to next week.
Read More
WHO emergency use authorisation to Covaxin delayed till October 5
Updated : 4 years, 8 months ago IST
New Delhi [India], September 18 (ANI): World Health Organisation's (WHO) approval for the emergency use authorisation (EUA) to COVID-19 vaccine Covaxin, developed by the Hyderabad-based Bharat Biotech, is likely to be delayed till October 5.
Read More
Will receive EUL for Covaxin from WHO at earliest, says Bharat Biotech
Updated : 4 years, 10 months ago IST
Hyderabad (Telangana) [India], July 12 (ANI): With a review process of 'Covaxin', the indigenous vaccine against COVID-19 commencing at the World Health Organisation (WHO), the Hyderabad-based Bharat Biotech on Monday said it expects to receive emergency use listing (EUL) from the global bod
Read More
Bharat Biotech releases Phase 3 trial results of Covaxin, claims vaccine e
Updated : 4 years, 11 months ago IST
Hyderabad (Telangana) [India], July 3 (ANI): Hyderabad-based Bharat Biotech on Saturday concluded a final analysis for its vaccine Covaxin efficacy from phase-3 clinical trial claiming it to be 77.8 per cent effective against COVID-19.
Read More
Bharat Biotech, WHO pre-submission meeting on June 23: WHO
Updated : 4 years, 11 months ago IST
New Delhi [India], June 17 (ANI): Hyderabad-based Bharat Biotech's pre-submission meeting has been scheduled on June 23 for evaluation of the World Health Organisation (WHO)'s Emergency Use Listing (EUL) of its indigenous COVID-19 vaccine Covaxin.
Read More
Ocugen Inc to have exclusive co-development, manufacturing rights of Covax
Updated : 5 years ago IST
Hyderabad (Telangana) [India], June 3 (ANI): Hyderabad-based Bharat Biotech on Thursday said that biopharmaceutical company Ocugen Inc will have exclusive co-development, manufacturing, and commercialisation rights of its COVID-19 vaccine Covaxin in Canada, in addition to its existing Uni
Read More